NO20040235L - Farmasoytisk preparat som omfatter faktor VII-polypeptider og faktor XI-polypeptider - Google Patents

Farmasoytisk preparat som omfatter faktor VII-polypeptider og faktor XI-polypeptider

Info

Publication number
NO20040235L
NO20040235L NO20040235A NO20040235A NO20040235L NO 20040235 L NO20040235 L NO 20040235L NO 20040235 A NO20040235 A NO 20040235A NO 20040235 A NO20040235 A NO 20040235A NO 20040235 L NO20040235 L NO 20040235L
Authority
NO
Norway
Prior art keywords
polypeptides
factor
pharmaceutical preparation
factor vii
vii polypeptides
Prior art date
Application number
NO20040235A
Other languages
English (en)
Norwegian (no)
Inventor
Rasmus Rojkjaer
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Publication of NO20040235L publication Critical patent/NO20040235L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20040235A 2001-07-20 2004-01-19 Farmasoytisk preparat som omfatter faktor VII-polypeptider og faktor XI-polypeptider NO20040235L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101127 2001-07-20
PCT/DK2002/000505 WO2003007983A1 (en) 2001-07-20 2002-07-19 Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides

Publications (1)

Publication Number Publication Date
NO20040235L true NO20040235L (no) 2004-03-17

Family

ID=8160632

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040235A NO20040235L (no) 2001-07-20 2004-01-19 Farmasoytisk preparat som omfatter faktor VII-polypeptider og faktor XI-polypeptider

Country Status (16)

Country Link
EP (1) EP1411973A1 (ko)
JP (1) JP2004534855A (ko)
KR (1) KR20040015821A (ko)
CN (1) CN1304050C (ko)
AU (1) AU2002354846B2 (ko)
BR (1) BR0211256A (ko)
CA (1) CA2452677A1 (ko)
CZ (1) CZ200439A3 (ko)
HU (1) HUP0400976A3 (ko)
IL (1) IL159622A0 (ko)
MX (1) MXPA04000415A (ko)
NO (1) NO20040235L (ko)
PL (1) PL369077A1 (ko)
RU (1) RU2298416C2 (ko)
WO (1) WO2003007983A1 (ko)
ZA (1) ZA200400012B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100411684C (zh) 1999-07-14 2008-08-20 诺沃挪第克健康护理股份公司 FVIIa或组织因子拮抗剂在调节基因表达和细胞迁移或趋化中的应用
CN1863908B (zh) 2003-09-09 2010-08-04 诺和诺德医疗保健公司 凝固因子ⅶ多肽
KR20060118486A (ko) * 2003-11-20 2006-11-23 노보 노르디스크 헬스 케어 악티엔게젤샤프트 인자 ｘｉ의 치료적 사용
CA2555025A1 (en) * 2004-02-05 2005-08-18 Novo Nordisk Health Care Ag Use of factor viia factor for treating trauma
WO2006128497A1 (en) * 2005-06-01 2006-12-07 Novo Nordisk A/S Pharmaceutical formulation of factor xi
LT2379096T (lt) 2008-12-19 2019-12-27 Baxalta GmbH Tfpi inhibitoriai ir vartojimo būdai
KR101784030B1 (ko) 2010-03-19 2017-10-10 백스터 인터내셔널 인코포레이티드 Tfpi 저해제 및 사용 방법
MX343784B (es) 2010-10-06 2016-11-23 Medimmune Ltd Factor ii y fibrinogeno para tratamiento de trastornos hemostaticos.
CN104302306B (zh) 2012-03-21 2019-03-22 百深有限责任公司 Tfpi抑制剂及其使用方法
MX2016009975A (es) * 2014-01-31 2016-10-31 Dana Farber Cancer Inst Inc Derivados de dihidropteridinona y sus usos.
AU2016276963C1 (en) 2015-06-12 2021-08-05 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
EP3380100A4 (en) 2015-11-25 2019-10-02 Dana-Farber Cancer Institute, Inc. BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF
US11958911B2 (en) 2017-02-10 2024-04-16 Shanghai Benemae Pharmaceutical Anti-coagulation factor XI antibody

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59116213A (ja) * 1982-12-24 1984-07-05 Unitika Ltd エアゾ−ル組成物
AU593042B2 (en) * 1985-11-26 1990-02-01 Novo Nordisk Health Care Ag Compositions and methods for the treatment of bleeding disorders
US5580560A (en) * 1989-11-13 1996-12-03 Novo Nordisk A/S Modified factor VII/VIIa
FR2676231A1 (fr) * 1991-05-07 1992-11-13 Aetsrn Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation.
WO2002022776A2 (en) * 2000-09-13 2002-03-21 Novo Nordisk A/S Human coagulation factor vii variants

Also Published As

Publication number Publication date
RU2298416C2 (ru) 2007-05-10
HUP0400976A2 (hu) 2004-08-30
HUP0400976A3 (en) 2006-01-30
BR0211256A (pt) 2004-07-27
WO2003007983A1 (en) 2003-01-30
MXPA04000415A (es) 2004-11-22
ZA200400012B (en) 2004-08-17
EP1411973A1 (en) 2004-04-28
KR20040015821A (ko) 2004-02-19
CA2452677A1 (en) 2003-01-30
PL369077A1 (en) 2005-04-18
CN1304050C (zh) 2007-03-14
CN1556710A (zh) 2004-12-22
CZ200439A3 (cs) 2005-03-16
JP2004534855A (ja) 2004-11-18
AU2002354846B2 (en) 2007-08-02
IL159622A0 (en) 2004-06-01
RU2004105031A (ru) 2005-04-20

Similar Documents

Publication Publication Date Title
NO2023030I1 (no) Apixaban and pharmaceutical acceptable salts thereof
NO20033143L (no) Farmasoytisk preparat
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20033556D0 (no) Farmasöytiske preparater
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20030418D0 (no) Nytt farmasöytisk preparat
NO20033785D0 (no) Farmasöytisk formulering
FI20011478A (fi) Farmaseuttinen koostumus
NO20035627D0 (no) Farmasöytisk formulering
NO20035315D0 (no) Farmasöytiske kombinasjoner
NO20040235L (no) Farmasoytisk preparat som omfatter faktor VII-polypeptider og faktor XI-polypeptider
NO20025805D0 (no) Farmasöytisk preparat
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid
NO20040214L (no) Kombinasjoner som innebefatter epotiloner og farmasoytiske anvendelser derav
NO20042380L (no) Farmasoytisk preparat omfattende faktor VII-polypeptider og faktor V-polypeptider
DE10291905D2 (de) Pharmazeutische Zusammensetzung
NO20042379L (no) Farmasoytisk preparat omfattende faktor VII-polypeptider og PAI-1-polypeptider
NO20015534D0 (no) Farmasöytisk blandeapparat
DE10107261B4 (de) Pharmazeutische Zusammensetzung
NO20041236L (no) Farmasoytisk formulering
DK200100256U3 (da) Amlodipinmaleat og farmaceutiske præparater indeholdende dette
SE0102572D0 (sv) Pharmaceutical formulation
SE0102957D0 (sv) Pharmaceutical formulation
SE0101325D0 (sv) Pharmaceutical formulation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application